Novo Nordisk stresses importance of keeping production going during an energy crisis
The Danish pharmaceutical giant already needs to keep factories operational almost 24/7 to meet demand, increasing the necessity of backup solutions should Denmark slide into an even worse energy situation.
by christopher due karlsson, translated by daniel pedersen
Novo Nordisk is lagging behind on several fronts when it comes to meeting demand for some products and is doing everything in its power to make sure the energy crisis won’t further impact production, according to the company’s CFO, Karsten Munk Knudsen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Danish life science is turning down the heat – literally
For subscribers
Novo Nordisk and Leo Pharma seek permission to use oil
For subscribers
